| Drug Name | PAXLOVID (Nirmatrelvir/ritonavir ) |
|---|---|
| Drug Class |
Anti-viral
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Infectious disease
|
| Risk |
dosing and dispensing in moderate renal impairment, and risk of serious adverse reactions due to drug interactions |
| Dear Healthcare provider letter DHPC |
|